Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (27836)	2/4/1999 4:12:00 PM
From: Cheryl Galt	Read Replies (1) \| Respond to of 32384

Bob, I see the same trend on the chart. Since the big major market drop, Ligand's trading range has been inching up. I expect that -- as has been true for similarly positioned ISIS since its small-market approval -- these two approvals will validate Ligand, and help dampen its price volatility. ---------------------- >> when it gets overhyped, it sets itself up for disappointment and a fall. << Amen! For example, for 3 years, I've seen what I call the "H&Q Effect." In the fluff of hype before the conference, the stock rises in December on the retail excitement, then tanks the day Ligand presents in "The Grand Ballroom." People get over-excited, then discouraged and upset. I'm fed up with it. (Just my interpretation...) BTW, I made that mistake in January 1997, bought in at over 16, on Presentation Day. What a greenhorn! But I've traded that position into a profit, long since. No problem. Yes, most of us know this stock pretty well. (the trend is our friend.) The Market is used to it too, and it's been a long time since we've gotten any mileage from analyst re-its. Ligand's day will come. But for a while longer, it's great to have a trading position in it, imo. ------------------ The FIRST news I'M hoping to see is an NDA filing for Targretin capsules for CTCL ---because THAT SYNCHS with the larger goal of getting good news for Targretin for ABC. IMO, if even ONE of the 3 arms of that trial turns out good, the stock eventually will do well. But this is the minimum I need to see, to hold this stock -- though I expect more. We shall see, near year end ... FWIW Cheryl